RP-G28

· Ritter Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for RP-G28, covering 2011-12-08 to 2019-07-08. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance [Phase 3]

See pricing